Literature DB >> 9443084

The role of nitric oxide in the immune response of tuberculosis.

O J Kwon1.   

Abstract

Nitric oxide (NO) formed by the action of inducible form of nitric oxide synthase (iNOS), reacts with oxygen radical forming reactive nitrogen intermediate (RNI). NO and related RNI have been reported to possess antimycobacterial activity. Macrophages can inhibit the proliferation of Mycobacterium tuberculosis by producing NO. In murine models, the ability of macrophages to produce NO can determine the susceptibility of the host to M. tuberculosis and the virulence of M. tuberculosis. However, it is still not clear whether NO is involved in the defense mechanism against M. tuberculosis in humans. We have demonstrated that human peripheral blood mononuclear cells (PBMC) and airway epithelial cells can express iNOS mRNA expression and produce NO production in response to tubercle bacilli stimulation. Furthermore, H37Ra, avirulent strain of M. tuberculosis, induces a larger amount of NO in cultured PBMC than H37Rv, virulent strain, does. There was no difference in NO production between healthy volunteers and patients with tuberculosis. NO production in airway epithelial cells is closely related with IFN gamma concentration. The balance of stimulatory cytokines and inhibitory cytokines for NO production may play a critical role in the defense mechanism against M. tuberculosis considering that NO production is upregulated by IFN gamma, TNF alpha, and IL-1 beta and downregulated by IL-10 and TGF beta. The study of immune response to M. tuberculosis including NO production may give us a better understanding of the pathogenesis of tuberculosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9443084      PMCID: PMC3054327          DOI: 10.3346/jkms.1997.12.6.481

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  18 in total

1.  Tumor necrosis factor signaling mediates resistance to mycobacteria by inhibiting bacterial growth and macrophage death.

Authors:  Hilary Clay; Hannah E Volkman; Lalita Ramakrishnan
Journal:  Immunity       Date:  2008-08-15       Impact factor: 31.745

Review 2.  Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens.

Authors:  C Nathan; M U Shiloh
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

3.  The role of nitric oxide in lung innate immunity: modulation by surfactant protein-A.

Authors:  Philip O'Reilly; Judy M Hickman-Davis; Philip McArdle; K Randall Young; Sadis Matalon
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

4.  Mycobacterium bovis BCG vaccination augments interleukin-8 mRNA expression and protein production in guinea pig alveolar macrophages infected with Mycobacterium tuberculosis.

Authors:  Mark J Lyons; Teizo Yoshimura; David N McMurray
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

5.  Direct EPR Detection of Nitric Oxide in Mice Infected with the Pathogenic Mycobacterium Mycobacterium tuberculosis.

Authors:  Anatoly F Vanin; Raisa P Selitskaya; Vladimir A Serezhenkov; Galina N Mozhokina
Journal:  Appl Magn Reson       Date:  2009-12-03       Impact factor: 0.831

6.  Differential expression of gamma interferon mRNA induced by attenuated and virulent Mycobacterium tuberculosis in guinea pig cells after Mycobacterium bovis BCG vaccination.

Authors:  Amminikutty Jeevan; Teizo Yoshimura; Kyeong Eun Lee; David N McMurray
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

7.  Dipterinyl calcium pentahydrate inhibits intracellular mycobacterial growth in human monocytes via the C-C chemokine MIP-1β and nitric oxide.

Authors:  Isaac G Sakala; Christopher S Eickhoff; Azra Blazevic; Phillip Moheno; Richard F Silver; Daniel F Hoft
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

8.  Impaired pulmonary nitric oxide bioavailability in pulmonary tuberculosis: association with disease severity and delayed mycobacterial clearance with treatment.

Authors:  Anna P Ralph; Tsin W Yeo; Cheryl M Salome; Govert Waramori; Gysje J Pontororing; Enny Kenangalem; Emiliana Tjitra; Richard Lumb; Graeme P Maguire; Ric N Price; Mark D Chatfield; Paul M Kelly; Nicholas M Anstey
Journal:  J Infect Dis       Date:  2013-06-03       Impact factor: 5.226

Review 9.  Biology of TNFalpha and IL-10, and their imbalance in heart failure.

Authors:  Kuljeet Kaur; Sanjiv Dhingra; Jan Slezak; Anita K Sharma; Anju Bajaj; Pawan K Singal
Journal:  Heart Fail Rev       Date:  2008-08-19       Impact factor: 4.214

10.  The role of nitric oxide in mycobacterial infections.

Authors:  Chul-Su Yang; Jae-Min Yuk; Eun-Kyeong Jo
Journal:  Immune Netw       Date:  2009-04-30       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.